Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Delarue

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Hand Surgery & Rehabilitation|February 2, 2019
Distal interphalangeal joint arthrodesis with the intramedullary Lync<sup>®</sup> implant: Prospective study of 22 casesP Auzias, R Delarue, G Strouk, et al.
Leukemia|September 24, 2004
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an updateF Lefrère, V Lévy, S François, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2019
Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemiaA Pouvaret, R Guery, M Montillet, et al.
La Revue De Medecine Interne|October 5, 2013
[Cardiac amyloidosis: a case series of 14 patients, description and prognosis]C Isabel, S Georgin-Lavialle, A Aouba, et al.
Bulletin Du Cancer|October 13, 2009
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]L Willems, F Suarez, E Messas, et al.
Leukemia & Lymphoma|October 27, 2006
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosisH Mossafa, D Damotte, A Jenabian, et al.
Gastroenterologie Clinique Et Biologique|November 6, 2010
Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectivesM-O Chandesris, G Malamut, V Verkarre, et al.
Kidney International|May 5, 2006
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literatureV Audard, F Larousserie, P Grimbert, et al.
Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Hand Surgery & Rehabilitation|February 2, 2019
Distal interphalangeal joint arthrodesis with the intramedullary Lync<sup>®</sup> implant: Prospective study of 22 casesP Auzias, R Delarue, G Strouk, et al.
Leukemia|September 24, 2004
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an updateF Lefrère, V Lévy, S François, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2019
Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemiaA Pouvaret, R Guery, M Montillet, et al.
La Revue De Medecine Interne|October 5, 2013
[Cardiac amyloidosis: a case series of 14 patients, description and prognosis]C Isabel, S Georgin-Lavialle, A Aouba, et al.
Bulletin Du Cancer|October 13, 2009
[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer]L Willems, F Suarez, E Messas, et al.
Leukemia & Lymphoma|October 27, 2006
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosisH Mossafa, D Damotte, A Jenabian, et al.
Gastroenterologie Clinique Et Biologique|November 6, 2010
Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectivesM-O Chandesris, G Malamut, V Verkarre, et al.
Kidney International|May 5, 2006
Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literatureV Audard, F Larousserie, P Grimbert, et al.
Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Pageof 3